KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Common Equity (2016 - 2025)

Petmed Express has reported Common Equity over the past 15 years, most recently at $32.8 million for Q4 2025.

  • For Q4 2025, Common Equity rose 82.37% year-over-year to $32.8 million; the TTM value through Dec 2025 reached $32.8 million, up 82.37%, while the annual FY2025 figure was $85.1 million, 18.98% up from the prior year.
  • Common Equity for Q4 2025 was $32.8 million at Petmed Express, up from $23.9 million in the prior quarter.
  • Over five years, Common Equity peaked at $130.7 million in Q4 2021 and troughed at $20000.0 in Q2 2021.
  • A 5-year average of $58.6 million and a median of $52.2 million in 2024 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: tumbled 99.98% in 2021 and later skyrocketed 374109.52% in 2023.
  • Year by year, Common Equity stood at $130.7 million in 2021, then fell by 12.13% to $114.9 million in 2022, then crashed by 79.57% to $23.5 million in 2023, then dropped by 23.46% to $18.0 million in 2024, then skyrocketed by 82.37% to $32.8 million in 2025.
  • Business Quant data shows Common Equity for PETS at $32.8 million in Q4 2025, $23.9 million in Q3 2025, and $32.4 million in Q2 2025.